SELP and cancer: Thus DEBIC shows the cross talk between tumor growth, arterial thrombosis, P-selectin expression, DNA intercalation and platelet activation, and thereby explores the advantage of P-selectin inhibition and DNA intercalation in chemical therapy of cancer patients to prevent the complication of arterial thrombosis.